| CRISPR/Cas9‐mediated genome engineering: an adeno‐associated viral (AAV) vector toolbox E Senís, C Fatouros, S Große, E Wiedtke, D Niopek, AK Mueller, K Börner, ... Biotechnology journal 9 (11), 1402-1412, 2014 | 335 | 2014 |
| Type I and type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut K Pervolaraki, ML Stanifer, S Münchau, LA Renn, D Albrecht, S Kurzhals, ... Frontiers in immunology 8, 459, 2017 | 97 | 2017 |
| AAV vector-mediated in vivo reprogramming into pluripotency E Senís, L Mosteiro, S Wilkening, E Wiedtke, A Nowrouzi, S Afzal, ... Nature Communications 9 (1), 2651, 2018 | 49 | 2018 |
| Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling E Kienle, E Senís, K Börner, D Niopek, E Wiedtke, S Grosse, D Grimm JoVE (Journal of Visualized Experiments), e3819, 2012 | 45 | 2012 |
| TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus E Senís, S Mockenhaupt, D Rupp, T Bauer, N Paramasivam, B Knapp, ... Nucleic acids research 45 (1), e3-e3, 2017 | 17 | 2017 |
| Regulation of adult CNS axonal regeneration by the post-transcriptional regulator Cpeb1 WPK Lou, A Mateos, M Koch, S Klussman, C Yang, N Lu, S Kumar, ... Frontiers in Molecular Neuroscience 10, 445, 2018 | 10 | 2018 |
| A therapeutic anti-Hepatitis C virus shmiRNA integrated into the miR-122 genomic locus mediates a potent anti-viral response E Senis, S Mockenhaupt, D Rupp, R Bartenschlager, D Grimm HUMAN GENE THERAPY 25 (11), A51-A52, 2014 | 2 | 2014 |
| A versatile in vivo system to study Myc in cell reprogramming E Senís, L Mosteiro, D Grimm, M Abad The Myc Gene: Methods and Protocols, 267-279, 2021 | 1 | 2021 |
| An AAV vector toolbox for CRISPR/Cas9-mediated genome engineering E Senis, C Fatouros, S Grosse, E Wiedtke, D Niopek, AK Mueller, ... HUMAN GENE THERAPY 25 (11), A24-A25, 2014 | 1 | 2014 |
| Efficient somatic cell reprogramming using low doses of self-complementary AAV-DJ vectors E Senis, D Grimm Human Gene Therapy 24 (12), A105-A105, 2013 | 1 | 2013 |
| An AAV Vector-Based Toolbox for Somatic Reprogramming and for iPS Cell Tracking and Purging E Senis, E Kienle, CA Fajardo, I Aydin, D Grimm Molecular Therapy 20, S204-S204, 2012 | 1 | 2012 |
| Post-transcriptional regulation of adult CNS axonal regeneration by Cpeb1 A Mateos, M Koch, S Klussman, C Yang, N Lu, S Limpert, M Göpferich, ... | | 2017 |
| Post-transcriptional regulation of adult CNS axonal regeneration by Cpeb1 W Pak-Kin Lou, A Mateos, M Koch, S Klussman, C Yang, N Lu, S Limpert, ... bioRxiv, 125096, 2017 | | 2017 |
| 470. New Insights into rAAV Integration Mechanisms by Targeted Enrichment Sequencing S Wilkening, S Afzal, E Senís, R Fronza, C von Kalle, D Grimm, M Schmidt Molecular Therapy 24, S186, 2016 | | 2016 |
| 300. AAV Vector-Mediated In Vivo Reprogramming of Various Cell Types in Adult Mice E Senís, L Mosteiro, S Wilkening, M Schmidt, M Serrano, D Grimm Molecular Therapy 23, S121, 2015 | | 2015 |
| ESGCT and NVGCT Collaborative Congress: The Hague-23 to 26 October Abstracts E Vroom, A Aartsma-Rus, RC Hoeben, H Büning, H Abken, M Pegtel, ... Human gene therapy 25 (11), A1-A121, 2014 | | 2014 |
| The European Society for Gene and Cell Therapy and the Spanish Society for Gene and Cell Therapy Collaborative Congress 2013 Conference Abstracts Palacio Municipal de Congresos … C Bonini, R Hernandez, J Canals, SJ Forbes, KM Champion, A Galy, ... Human Gene Therapy 24 (12), A1-A172, 2013 | | 2013 |
| From Mice to Men: Towards the Clinical Translation of miRNA Technologies for Somatic Cell Reprogramming E Senís, D Grimm | | |
